...
首页> 外文期刊>Renal failure. >Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients
【24h】

Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients

机译:II型糖尿病患者心导管插入后造影剂肾病的发生频率和危险因素:埃及患者的一项研究

获取原文
           

摘要

Contrast-induced nephropathy (CIN) is the third leading cause of acute kidney injury (AKI) in hospitalized patients. Diabetes mellitus remains a consistent independent predictor of contrast nephropathy. Aim: To determine frequency and predictors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients. Patients and methods: The study included 200 type II diabetic patients who underwent cardiac catheterization; serial measurement of serum creatinine and creatinine clearance (Before contrast exposure and 48?h), creatinine clearance was calculated using Cockcroft–Gault formula. Contrast-induced nephropathy was defined as rise in serum creatinine 48?h after contrast exposure of ≥0.5?mg/dL or increased >25% compared to base line creatinine. Results: incidence of CIN in type II diabetic patients was 21.5%; incidence of CIN in diabetic patients with microalbuminuria was 17%, while incidence of CIN in patients with macroalbuminuria levels was 26%. There was a statistically significant difference between the patients who suffered from CIN post-procedure and patients who did not suffer from CIN regarding the ejection fraction and age with low ejection fraction and older patients in CIN group. Multiple logistic regression analysis for CIN predictors showed that pre-contrast serum creatinine to be the strongest predictor for being at risk of contrast-related, followed by age, and lastly albumin/creatinine ratio. Conclusion: Our findings suggest that diabetic patients, despite having a normal baseline creatinine are at an increased risk of developing CIN post-coronary angiography, patients at risk of CIN are older patients with high pre-contrast serum creatinine and high urine albumin/creatinine ratio.
机译:对比肾病(CIN)是住院患者急性肾损伤(AKI)的第三大主要原因。糖尿病仍然是造影剂肾病的一致独立预测因子。目的:确定II型糖尿病患者心脏导管插入后造影剂诱发的肾病的频率和预测因素。患者和方法:该研究包括200名接受心脏导管插入术的II型糖尿病患者。血清肌酐和肌酐清除率的连续测量(在对比暴露和48 h之前),使用Cockcroft-Gault公式计算肌酐清除率。造影剂诱发的肾病定义为对比暴露≥0.5?mg / dL或与基线肌酐相比,血肌酐升高48?h或增加> 25%。结果:II型糖尿病患者的CIN发生率为21.5%;糖尿病合并微量白蛋白尿的患者中CIN的发生率为17%,而大量白蛋白尿患者的CIN的发生率为26%。在CIN组中,射血分数和低射血分数的年龄与年龄较大的患者相比,术后CIN的患者与未患CIN的患者之间存在统计学差异。对CIN预测因素的多重logistic回归分析表明,对比前血清肌酐是最有可能出现造影剂相关风险的预测指标,其次是年龄,最后是白蛋白/肌酐比率。结论:我们的发现表明,尽管基线肌酐水平正常的糖尿病患者冠状动脉造影后发生CIN的风险增加,但存在CIN风险的患者是造影剂血清肌酐水平较高和尿白蛋白/肌酐比率较高的老年患者。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号